Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 2, 2025Archives of Disease in Childhood

Seroprevalence of measles antibodies in children with cancer: results of a 2024 UK service evaluation

View Full Paper
Ask AI
Bookmark
Share

Authors

CCClaire CuerdenRCRebecca CorderyKBKevin Brown

Discussion

Loading...

Member takes

Overview

Multicentre evaluation reports 89% measles seroprevalence in children with cancer, highlighting variability in testing practices.

Key Points

  • A total of 695 children with cancer were evaluated, with 89% showing positive measles IgG antibodies.
  • Among those retested, 19% of previously seropositive patients lost immunity, indicating a risk during cancer treatment.
  • Evaluating measles serology in pediatric oncology patients highlights significant gaps in testing consistency.
  • Standardized retesting during measles outbreaks is critical for identifying children needing protection against infection.

Cite This Study

Cuerden et al. (2025) studied this question.

synapsesocial.com/papers/68de68f183cbc991d0a216aahttps://doi.org/10.1136/archdischild-2025-328968
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Seroprevalence of Measles (Rubeola) Antibodies in Childhood Cancer Survivors2024 · 1 citations
  2. 2Vaccination against Measles in Patients with Oncological Disease2024
  3. 3[Evaluation of changes in serum measles antibody levels in children with tumors before and after chemotherapy and the necessity of revaccination with measles-containing vaccines].2025
  4. 4Cross-sectional seroprevalence study of measles antibodies among children to identify gaps in population immunity, Ireland, 20242026
  5. 5Loss of Measles, Mumps, and Rubella Immunity in Pediatric Cancer Survivors Following Chemotherapy2025